The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options
✍ Scribed by Giancarlo Agnelli; Joseph A. Caprini
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 117 KB
- Volume
- 96
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Cancer is a risk factor for venous thromboembolism (VTE). This risk is amplified by treatment with chemotherapy, radiation, or surgery. Thus, patients with cancer undergoing major surgery should receive appropriate prophylaxis. Available agents include low‐dose unfractionated heparin (LDUH), low‐molecular‐weight heparin (LMWH), and Factor Xa inhibitors. Recent data suggest that Factor Xa inhibitors are safe and effective for VTE prevention in patients with cancer undergoing abdominal surgery. Further study in this patient population is warranted. J. Surg. Oncol. 2007;96: 265–272. © 2007 Wiley‐Liss, Inc.